Trisalus Life Sciences, Inc. · NASDAQ:TLSI

Frankenius Equity AB reported a 20.50% stake in Trisalus Life Sciences, Inc. (Schedule 13D/A)

Event Apr 30, 2025 · Filed May 2, 2025

Frankenius Equity AB reported a 20.50% stake in Trisalus Life Sciences, Inc., 6,732,516 shares, with active intent on Apr 30, 2025. Filed May 2, 2025 (Schedule 13D/A).

Stake
20.50%
Shares
6,732,516
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Frankenius Equity AB20.50%6,732,516
Paul Frankenius20.50%6,732,516

Source

View original at SEC

Related